Sei Investments CO Beam Therapeutics Inc. Transaction History

Sei Investments CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$29.32 - $35.99 $209,403 - $257,040	7,142 New	7,142 $228,000
Q4 2022 Feb 10, 2023	SELL	$36.73 - $51.6 $129,877 - $182,457	-3,536 Reduced 38.31%	5,693 $222,000
Q3 2022 Nov 14, 2022	BUY	$39.79 - $70.31 $367,221 - $648,890	9,229 New	9,229 $440,000
Q3 2021 Nov 12, 2021	SELL	$84.37 - $133.6 $146,803 - $232,464	-1,740 Closed	0 $0
Q2 2021 Aug 06, 2021	SELL	$64.12 - $128.71 $556,497 - $1.12 Million	-8,679 Reduced 83.3%	1,740 $224,000
Q4 2020 Feb 08, 2021	BUY	$22.24 - $95.63 $231,718 - $996,368	10,419 New	10,419 $851,000

236

75.2M

438K

232K

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.78B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

Stay updated on Sei Investments CO with notifications on news.